2022.12.21Press Release【Press Release】 Shonan iPark Outlines New Operational Structure to Provide Scale and Sustainable Long-Term Growth for the Ecosystem
2022.09.28Press Release【Press Release】Shonan iPark Announces Finalists of its Second Incubation Program: “Japan Innovation Bloom GRANT CALL 2022”
2022.07.13Media Coverage【Media Coverage】Toshio Fujimoto, General Manager of Shonan iPark, was interviewed by Sankei Newspaper regarding the creation of an effective drug discovery ecosystem in Japan “Reviving the Pharmaceutical Industry: Overcoming Vaccine Defeat”
2022.05.13Press Release【Press Release】Shonan iPark Collaborates with Johnson & Johnson Innovation, Janssen Research & Development, LLC, and Takeda Pharmaceutical Company Limited to Launch Japan Innovation Bloom GRANT CALL 2022
2022.03.24Press Release【Press Release】Shonan iPark Signs Memorandum of Understanding for Strategic Alliance with Chinese Science Park ‘Suzhou Industrial Park’
2021.12.01Press Release【Press Release】ARTham Therapeutics, Inc. Enters into Share Transfer Agreement with Kaken Pharmaceutical Co., Ltd.
2021.08.10Announcement【Tenant’s News】New company “Orizuru Therapeutics Inc.” launched from T-CiRA in Shonan iPark.
2021.06.22Press Release【Press Release】iPark Invites Companies to Join Second Phase of “Japan VC Consortium,”a Platform Driving VC, CVC, and Pharmaceutical Company Collaboration
2021.04.21Press Release【Press Release】Muraoka-Fukasawa District Transforms into Cutting-Edge Center for Health Innovation
2021.04.15Press Release【Press Release】New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry
